LGND insider 10b5-1 sales and option exercises

LGND filing: Notice of proposed sale under Rule 144 reporting planned dispositions of Common Stock by an insider.

Rhea-AI Filing Summary

LGND filing: Notice of proposed sale under Rule 144 reporting planned dispositions of Common Stock by an insider. The excerpt lists 10b5-1 sales on 03/04/2026 for 13,423 shares and a sale on 12/12/2025 for 1,804 shares. It also shows exercises of stock options on 03/11/2026 (reported 2,405 shares) and earlier on 12/16/2025 (652 shares). The transactions are reported as planned 10b5-1 sales and option exercises; cash consideration amounts are shown for each sale row.

Insights

Securities Compliance Expert

Routine Rule 144 notice of planned insider dispositions under a trading plan.

The filing records 10b5-1 sales and option exercises with exact share counts: 13,423 shares on 03/04/2026 and 1,804 shares on 12/12/2025. It lists option exercises on 03/11/2026 and 12/16/2025.

These entries align with standard compliance disclosures; cash amounts are presented per row. Subsequent public filings will show consummation details if required.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions does LGND's Form 144 report?

The Form 144 reports planned insider sales and option exercises by an executive. It lists 10b5-1 sales of 13,423 shares on 03/04/2026 and 1,804 shares on 12/12/2025, plus option exercises of 2,405 and 652 shares on 03/11/2026 and 12/16/2025.

Who is identified as the selling party in the LGND filing?

The filing identifies Octavio Espinoza with an address in Jupiter, FL, as the reporting person. The record shows his 10b5-1 sales and related cash amounts in the rows provided, consistent with a reporting insider using a pre-arranged trading plan.

Are the LGND sales reported as part of a 10b5-1 plan?

Yes, the Form 144 rows explicitly label the sales as 10b5-1 Sales. The entries show planned dispositions on 03/04/2026 and 12/12/2025, indicating these transactions were executed under a pre-arranged trading arrangement as disclosed in the excerpt.

Do the Form 144 rows show cash amounts received from the sales?

Yes, each sale row lists cash consideration values alongside share counts. For example, the 13,423 share sale on 03/04/2026 shows $2,762,822.25 and the 1,804 share sale on 12/12/2025 shows $339,711.24 in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 04:42 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001905248
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LIGAND PHARMACEUTICALS INC
SEC File Number	001-33093
Address of Issuer	555 Heritage Drive, Suite 200 Jupiter FLORIDA 33458
Phone	858-550-7500
Name of Person for Whose Account the Securities are To Be Sold	OCTAVIO ESPINOZA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3057	648970.53	19941141	03/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/11/2026	Exercise of Stock Options	Issuer			2405	03/11/2026	Cash
Common	12/16/2025	Previously Exercised Stock Options	Issuer			652	12/16/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for OCTAVIO ESPINOZA 555 Heritage Drive, Suite 200 Jupiter FL 33458	Common	03/04/2026	13423	2762822.25
OCTAVIO ESPINOZA 555 Heritage Drive, Suite 200 Jupiter FL 33458	Common	12/12/2025	1804	339711.24

144: Remarks and Signature

Remarks
Date of Notice	03/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Octavio Espinoza
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)